- Report
- July 2024
- 258 Pages
Global
From €4252EUR$4,455USD£3,562GBP
€4724EUR$4,950USD£3,958GBP
- Report
- October 2024
- 194 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- February 2025
- 100 Pages
Europe
From €3102EUR$3,250USD£2,599GBP
- Report
- July 2024
- 82 Pages
Japan
From €3340EUR$3,500USD£2,799GBP
- Report
- June 2023
- 114 Pages
Global
From €4295EUR$4,500USD£3,598GBP
The Hematologic Malignancies Testing market is a subset of the Diagnostics industry, focusing on the detection and diagnosis of blood-related cancers. Tests are used to detect the presence of cancerous cells in the blood, bone marrow, and lymph nodes. These tests can also be used to monitor the progression of the disease and to determine the best course of treatment. Common tests include flow cytometry, immunophenotyping, and cytogenetic analysis.
The Hematologic Malignancies Testing market is highly competitive, with a range of companies offering tests and services. These include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Danaher Corporation, and Roche Diagnostics. Show Less Read more